chris parrish is a researcher at australian national university and he has devoted his entire career, 20 years to a liver cancer drug, a promising liver cancer drug. it was in stage iii trials. it was doing extremely well. was called pia a eight and it looks promising. he acquired a corporate partner and he was happy about that because his corporate partner allowed him to finish work on the drug, have attested and funded its research. he didn't really care he said that when he parted with his group through his university, they told him luck, we have to license or sell the patent to this new health pharma, this new company so you no longer on the patent. he said i don't care, i just want them to devise a drug and he did. at the end of the stage iii trials before was about to attain approval they shut it down. they ended the trial. we don't want it and we are not going to market it. why didn't they wanted? it's a liver cancer drug and although it's not a large problem in this country liver cancers the cancer is the number three killer globally and they're not that many good drugs for it